New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.
作者信息
Abdool Karim Salim S, de Oliveira Tulio
机构信息
Centre for the AIDS Program of Research in South Africa, Durban, South Africa
KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Durban, South Africa.
出版信息
N Engl J Med. 2021 May 13;384(19):1866-1868. doi: 10.1056/NEJMc2100362. Epub 2021 Mar 24.
Abstract
摘要
相似文献
1
New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.
N Engl J Med. 2021 May 13;384(19):1866-1868. doi: 10.1056/NEJMc2100362. Epub 2021 Mar 24.
2
Coronavirus variants are spreading in India - what scientists know so far.
Nature. 2021 May;593(7859):321-322. doi: 10.1038/d41586-021-01274-7.
3
Audio Interview: The Omicron Variant of SARS-CoV-2.
N Engl J Med. 2021 Dec 2;385(23):e96. doi: 10.1056/NEJMe2118839.
4
Fast-spreading COVID variant can elude immune responses.
Nature. 2021 Jan;589(7843):500-501. doi: 10.1038/d41586-021-00121-z.
5
The long road.
Science. 2021 Feb 19;371(6531):768-772. doi: 10.1126/science.371.6531.768.
6
Pfizer COVID vaccine protects against worrying coronavirus variants.
Nature. 2021 May;593(7859):325-326. doi: 10.1038/d41586-021-01222-5.
7
Heavily mutated Omicron variant puts scientists on alert.
Nature. 2021 Dec;600(7887):21. doi: 10.1038/d41586-021-03552-w.
8
Audio Interview: Vaccination and Variants in the U.S. and South Africa.
N Engl J Med. 2021 May 13;384(19):e85. doi: 10.1056/NEJMe2108162.
9
Omicron's feeble attack on the lungs could make it less dangerous.
Nature. 2022 Jan;601(7892):177. doi: 10.1038/d41586-022-00007-8.
10
Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
N Engl J Med. 2021 Sep 16;385(12):e48. doi: 10.1056/NEJMe2115200.
引用本文的文献
1
The Role of NEU1 in Coronavirus Infection and Pathogenesis.
Virol Immunol J. 2024;8(3). doi: 10.23880/vij-16000351. Epub 2024 Aug 8.
2
SARS-CoV-2 epidemiology, kinetics, and evolution: A narrative review.
Virulence. 2025 Dec;16(1):2480633. doi: 10.1080/21505594.2025.2480633. Epub 2025 Apr 8.
3
Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine.
Front Public Health. 2025 Jan 28;13:1478627. doi: 10.3389/fpubh.2025.1478627. eCollection 2025.
4
Clinical characterization, molecular and genomic sequencing analysis of SARS-Cov-2 during second wave at Raigarh, Chhattisgarh, India.
Bioinformation. 2024 Sep 30;20(9):1059-1064. doi: 10.6026/9732063002001059. eCollection 2024.
5
Advancements in Structural Basis of Covalent Inhibitors Targeting SARS-CoV-2 Essential Proteins.
Curr Med Chem. 2025;32(19):3790-3824. doi: 10.2174/0109298673323348241208080419.
6
Human respiratory organoids sustained reproducible propagation of human rhinovirus C and elucidation of virus-host interaction.
Nat Commun. 2024 Dec 30;15(1):10772. doi: 10.1038/s41467-024-55076-2.
7
Dentists' Stress During the COVID-19 Pandemic: A Repeated Cross-Sectional Study.
Int Dent J. 2023 Oct 27;74(2):294-302. doi: 10.1016/j.identj.2023.09.006.
8
A colorimetric reverse-transcription loop-mediated isothermal amplification method targeting the L452R mutation to detect the Delta variant of SARS-CoV-2.
Sci Rep. 2024 Sep 20;14(1):21961. doi: 10.1038/s41598-024-72417-9.
9
QnAs with Quarraisha Abdool Karim and Salim Abdool Karim: Winners of the 2024 Lasker~Bloomberg Public Service Award.
Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2416096121. doi: 10.1073/pnas.2416096121. Epub 2024 Sep 19.
10
A Comparative Analysis of SARS-CoV-2 Variants of Concern (VOC) Spike Proteins Interacting with hACE2 Enzyme.
Int J Mol Sci. 2024 Jul 23;25(15):8032. doi: 10.3390/ijms25158032.
本文引用的文献
1
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.abg3055. Epub 2021 Mar 3.
2
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.
Nat Med. 2021 Apr;27(4):622-625. doi: 10.1038/s41591-021-01285-x. Epub 2021 Mar 2.
Zotero 插件